Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Rapid Antigen Testing (RAT) for COVID-19 Market Growth 2022-2028

  • LP 4957910
  • 129 Pages
  • May 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Rapid Antigen Testing (RAT) for COVID-19 will have significant change from previous year. According to our (LP Information) latest study, the global Rapid Antigen Testing (RAT) for COVID-19 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rapid Antigen Testing (RAT) for COVID-19 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Rapid Antigen Testing (RAT) for COVID-19 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Rapid Antigen Testing (RAT) for COVID-19 market, reaching US$ million by the year 2028. As for the Europe Rapid Antigen Testing (RAT) for COVID-19 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Rapid Antigen Testing (RAT) for COVID-19 players cover Abbott, Quidel, ACCESS BIO, and CTK Biotech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Antigen Testing (RAT) for COVID-19 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Fluorescence Immunochromatography

Colloidal Gold Immunochromatography

Latex Immunochromatography

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Community Testing

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Abbott

Quidel

ACCESS BIO

CTK Biotech

SD Biosensor

Ellume

InBios

Celltrion

AESKU.GROUP

ROCHE

BD

OraSure Technologies

Clip Health

LumiraDx

Princeton BioMeditech Corporation

RapiGEN Inc.

Orient Gene

Wondfo Biotech

Ihealth (Andon Health)

Wantai BioPharm

Biotest Biotech

Shenzhen YHLO Biotech

Vazyme Biotech

EasyDiagnosis Biomedicine

Beijing Hotgen Biotech

Assure Tech

Hangzhou AllTest Biotech

ACON Biotech

BGI Genomics

Lepu Medical Technology

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Rapid Antigen Testing (RAT) for COVID-19 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Rapid Antigen Testing (RAT) for COVID-19 by Country/Region, 2017, 2022 & 2028

2.2 Rapid Antigen Testing (RAT) for COVID-19 Segment by Type

2.2.1 Fluorescence Immunochromatography

2.2.2 Colloidal Gold Immunochromatography

2.2.3 Latex Immunochromatography

2.2.4 Others

2.3 Rapid Antigen Testing (RAT) for COVID-19 Sales by Type

2.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)

2.3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Type (2017-2022)

2.4 Rapid Antigen Testing (RAT) for COVID-19 Segment by Application

2.4.1 Hospitals

2.4.2 Community Testing

2.4.3 Other

2.5 Rapid Antigen Testing (RAT) for COVID-19 Sales by Application

2.5.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Market Share by Application (2017-2022)

2.5.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Application (2017-2022)

3 Global Rapid Antigen Testing (RAT) for COVID-19 by Company

3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Breakdown Data by Company

3.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales by Company (2020-2022)

3.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Company (2020-2022)

3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue by Company (2020-2022)

3.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Company (2020-2022)

3.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Company (2020-2022)

3.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Company

3.4 Key Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Product Location Distribution

3.4.2 Players Rapid Antigen Testing (RAT) for COVID-19 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Rapid Antigen Testing (RAT) for COVID-19 by Geographic Region

4.1 World Historic Rapid Antigen Testing (RAT) for COVID-19 Market Size by Geographic Region (2017-2022)

4.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue by Geographic Region

4.2 World Historic Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country/Region (2017-2022)

4.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue by Country/Region

4.3 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales Growth

4.4 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales Growth

4.5 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Growth

4.6 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Growth

5 Americas

5.1 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Country

5.1.1 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022)

5.1.2 Americas Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022)

5.2 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Type

5.3 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Region

6.1.1 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2017-2022)

6.1.2 APAC Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2017-2022)

6.2 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Type

6.3 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Rapid Antigen Testing (RAT) for COVID-19 by Country

7.1.1 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022)

7.1.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022)

7.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Type

7.3 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 by Country

8.1.1 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022)

8.2 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Type

8.3 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Rapid Antigen Testing (RAT) for COVID-19

10.3 Manufacturing Process Analysis of Rapid Antigen Testing (RAT) for COVID-19

10.4 Industry Chain Structure of Rapid Antigen Testing (RAT) for COVID-19

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Rapid Antigen Testing (RAT) for COVID-19 Distributors

11.3 Rapid Antigen Testing (RAT) for COVID-19 Customer

12 World Forecast Review for Rapid Antigen Testing (RAT) for COVID-19 by Geographic Region

12.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size Forecast by Region

12.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Forecast by Region (2023-2028)

12.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Rapid Antigen Testing (RAT) for COVID-19 Forecast by Type

12.7 Global Rapid Antigen Testing (RAT) for COVID-19 Forecast by Application

13 Key Players Analysis

13.1 Abbott

13.1.1 Abbott Company Information

13.1.2 Abbott Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.1.3 Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Main Business Overview

13.1.5 Abbott Latest Developments

13.2 Quidel

13.2.1 Quidel Company Information

13.2.2 Quidel Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.2.3 Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Quidel Main Business Overview

13.2.5 Quidel Latest Developments

13.3 ACCESS BIO

13.3.1 ACCESS BIO Company Information

13.3.2 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.3.3 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 ACCESS BIO Main Business Overview

13.3.5 ACCESS BIO Latest Developments

13.4 CTK Biotech

13.4.1 CTK Biotech Company Information

13.4.2 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.4.3 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 CTK Biotech Main Business Overview

13.4.5 CTK Biotech Latest Developments

13.5 SD Biosensor

13.5.1 SD Biosensor Company Information

13.5.2 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.5.3 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 SD Biosensor Main Business Overview

13.5.5 SD Biosensor Latest Developments

13.6 Ellume

13.6.1 Ellume Company Information

13.6.2 Ellume Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.6.3 Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ellume Main Business Overview

13.6.5 Ellume Latest Developments

13.7 InBios

13.7.1 InBios Company Information

13.7.2 InBios Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.7.3 InBios Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 InBios Main Business Overview

13.7.5 InBios Latest Developments

13.8 Celltrion

13.8.1 Celltrion Company Information

13.8.2 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.8.3 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Celltrion Main Business Overview

13.8.5 Celltrion Latest Developments

13.9 AESKU.GROUP

13.9.1 AESKU.GROUP Company Information

13.9.2 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.9.3 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 AESKU.GROUP Main Business Overview

13.9.5 AESKU.GROUP Latest Developments

13.10 ROCHE

13.10.1 ROCHE Company Information

13.10.2 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.10.3 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 ROCHE Main Business Overview

13.10.5 ROCHE Latest Developments

13.11 BD

13.11.1 BD Company Information

13.11.2 BD Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.11.3 BD Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 BD Main Business Overview

13.11.5 BD Latest Developments

13.12 OraSure Technologies

13.12.1 OraSure Technologies Company Information

13.12.2 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.12.3 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 OraSure Technologies Main Business Overview

13.12.5 OraSure Technologies Latest Developments

13.13 Clip Health

13.13.1 Clip Health Company Information

13.13.2 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.13.3 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Clip Health Main Business Overview

13.13.5 Clip Health Latest Developments

13.14 LumiraDx

13.14.1 LumiraDx Company Information

13.14.2 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.14.3 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 LumiraDx Main Business Overview

13.14.5 LumiraDx Latest Developments

13.15 Princeton BioMeditech Corporation

13.15.1 Princeton BioMeditech Corporation Company Information

13.15.2 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.15.3 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Princeton BioMeditech Corporation Main Business Overview

13.15.5 Princeton BioMeditech Corporation Latest Developments

13.16 RapiGEN Inc.

13.16.1 RapiGEN Inc. Company Information

13.16.2 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.16.3 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 RapiGEN Inc. Main Business Overview

13.16.5 RapiGEN Inc. Latest Developments

13.17 Orient Gene

13.17.1 Orient Gene Company Information

13.17.2 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.17.3 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Orient Gene Main Business Overview

13.17.5 Orient Gene Latest Developments

13.18 Wondfo Biotech

13.18.1 Wondfo Biotech Company Information

13.18.2 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.18.3 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Wondfo Biotech Main Business Overview

13.18.5 Wondfo Biotech Latest Developments

13.19 Ihealth (Andon Health)

13.19.1 Ihealth (Andon Health) Company Information

13.19.2 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.19.3 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Ihealth (Andon Health) Main Business Overview

13.19.5 Ihealth (Andon Health) Latest Developments

13.20 Wantai BioPharm

13.20.1 Wantai BioPharm Company Information

13.20.2 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.20.3 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Wantai BioPharm Main Business Overview

13.20.5 Wantai BioPharm Latest Developments

13.21 Biotest Biotech

13.21.1 Biotest Biotech Company Information

13.21.2 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.21.3 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Biotest Biotech Main Business Overview

13.21.5 Biotest Biotech Latest Developments

13.22 Shenzhen YHLO Biotech

13.22.1 Shenzhen YHLO Biotech Company Information

13.22.2 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.22.3 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Shenzhen YHLO Biotech Main Business Overview

13.22.5 Shenzhen YHLO Biotech Latest Developments

13.23 Vazyme Biotech

13.23.1 Vazyme Biotech Company Information

13.23.2 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.23.3 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Vazyme Biotech Main Business Overview

13.23.5 Vazyme Biotech Latest Developments

13.24 EasyDiagnosis Biomedicine

13.24.1 EasyDiagnosis Biomedicine Company Information

13.24.2 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.24.3 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 EasyDiagnosis Biomedicine Main Business Overview

13.24.5 EasyDiagnosis Biomedicine Latest Developments

13.25 Beijing Hotgen Biotech

13.25.1 Beijing Hotgen Biotech Company Information

13.25.2 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.25.3 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Beijing Hotgen Biotech Main Business Overview

13.25.5 Beijing Hotgen Biotech Latest Developments

13.26 Assure Tech

13.26.1 Assure Tech Company Information

13.26.2 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.26.3 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Assure Tech Main Business Overview

13.26.5 Assure Tech Latest Developments

13.27 Hangzhou AllTest Biotech

13.27.1 Hangzhou AllTest Biotech Company Information

13.27.2 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.27.3 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Hangzhou AllTest Biotech Main Business Overview

13.27.5 Hangzhou AllTest Biotech Latest Developments

13.28 ACON Biotech

13.28.1 ACON Biotech Company Information

13.28.2 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.28.3 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 ACON Biotech Main Business Overview

13.28.5 ACON Biotech Latest Developments

13.29 BGI Genomics

13.29.1 BGI Genomics Company Information

13.29.2 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.29.3 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 BGI Genomics Main Business Overview

13.29.5 BGI Genomics Latest Developments

13.30 Lepu Medical Technology

13.30.1 Lepu Medical Technology Company Information

13.30.2 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product Offered

13.30.3 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)

13.30.4 Lepu Medical Technology Main Business Overview

13.30.5 Lepu Medical Technology Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Rapid Antigen Testing (RAT) for COVID-19 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Rapid Antigen Testing (RAT) for COVID-19 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Fluorescence Immunochromatography

Table 4. Major Players of Colloidal Gold Immunochromatography

Table 5. Major Players of Latex Immunochromatography

Table 6. Major Players of Others

Table 7. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2022) & (K Units)

Table 8. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)

Table 9. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2017-2022) & ($ million)

Table 10. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2017-2022)

Table 11. Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2017-2022) & (K Units)

Table 13. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)

Table 14. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2017-2022)

Table 15. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2017-2022)

Table 16. Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Company (2020-2022) & (K Units)

Table 18. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Company (2020-2022)

Table 19. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Company (2020-2022)

Table 21. Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Producing Area Distribution and Sales Area

Table 23. Players Rapid Antigen Testing (RAT) for COVID-19 Products Offered

Table 24. Rapid Antigen Testing (RAT) for COVID-19 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share Geographic Region (2017-2022)

Table 29. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country/Region (2017-2022)

Table 33. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022) & (K Units)

Table 36. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2017-2022)

Table 37. Americas Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2017-2022)

Table 39. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2022) & (K Units)

Table 40. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)

Table 41. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2017-2022) & (K Units)

Table 42. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)

Table 43. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2017-2022) & (K Units)

Table 44. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2017-2022)

Table 45. APAC Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2017-2022)

Table 47. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2022) & (K Units)

Table 48. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)

Table 49. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2017-2022) & (K Units)

Table 50. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)

Table 51. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022) & (K Units)

Table 52. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2017-2022)

Table 53. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2017-2022)

Table 55. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2022) & (K Units)

Table 56. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)

Table 57. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2017-2022) & (K Units)

Table 58. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Rapid Antigen Testing (RAT) for COVID-19

Table 68. Key Market Challenges & Risks of Rapid Antigen Testing (RAT) for COVID-19

Table 69. Key Industry Trends of Rapid Antigen Testing (RAT) for COVID-19

Table 70. Rapid Antigen Testing (RAT) for COVID-19 Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Rapid Antigen Testing (RAT) for COVID-19 Distributors List

Table 73. Rapid Antigen Testing (RAT) for COVID-19 Customer List

Table 74. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Forecast by Region

Table 76. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share Forecast by Application (2023-2028)

Table 94. Abbott Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 95. Abbott Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 96. Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Abbott Main Business

Table 98. Abbott Latest Developments

Table 99. Quidel Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 100. Quidel Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 101. Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Quidel Main Business

Table 103. Quidel Latest Developments

Table 104. ACCESS BIO Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 105. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 106. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. ACCESS BIO Main Business

Table 108. ACCESS BIO Latest Developments

Table 109. CTK Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 110. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 111. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. CTK Biotech Main Business

Table 113. CTK Biotech Latest Developments

Table 114. SD Biosensor Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 115. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 116. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. SD Biosensor Main Business

Table 118. SD Biosensor Latest Developments

Table 119. Ellume Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 120. Ellume Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 121. Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Ellume Main Business

Table 123. Ellume Latest Developments

Table 124. InBios Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 125. InBios Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 126. InBios Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. InBios Main Business

Table 128. InBios Latest Developments

Table 129. Celltrion Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 130. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 131. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Celltrion Main Business

Table 133. Celltrion Latest Developments

Table 134. AESKU.GROUP Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 135. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 136. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. AESKU.GROUP Main Business

Table 138. AESKU.GROUP Latest Developments

Table 139. ROCHE Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 140. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 141. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. ROCHE Main Business

Table 143. ROCHE Latest Developments

Table 144. BD Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 145. BD Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 146. BD Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. BD Main Business

Table 148. BD Latest Developments

Table 149. OraSure Technologies Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 150. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 151. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. OraSure Technologies Main Business

Table 153. OraSure Technologies Latest Developments

Table 154. Clip Health Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 155. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 156. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Clip Health Main Business

Table 158. Clip Health Latest Developments

Table 159. LumiraDx Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 160. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 161. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. LumiraDx Main Business

Table 163. LumiraDx Latest Developments

Table 164. Princeton BioMeditech Corporation Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 165. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 166. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Princeton BioMeditech Corporation Main Business

Table 168. Princeton BioMeditech Corporation Latest Developments

Table 169. RapiGEN Inc. Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 170. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 171. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. RapiGEN Inc. Main Business

Table 173. RapiGEN Inc. Latest Developments

Table 174. Orient Gene Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 175. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 176. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. Orient Gene Main Business

Table 178. Orient Gene Latest Developments

Table 179. Wondfo Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 180. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 181. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 182. Wondfo Biotech Main Business

Table 183. Wondfo Biotech Latest Developments

Table 184. Ihealth (Andon Health) Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 185. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 186. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 187. Ihealth (Andon Health) Main Business

Table 188. Ihealth (Andon Health) Latest Developments

Table 189. Wantai BioPharm Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 190. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 191. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 192. Wantai BioPharm Main Business

Table 193. Wantai BioPharm Latest Developments

Table 194. Biotest Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 195. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 196. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 197. Biotest Biotech Main Business

Table 198. Biotest Biotech Latest Developments

Table 199. Shenzhen YHLO Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 200. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 201. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 202. Shenzhen YHLO Biotech Main Business

Table 203. Shenzhen YHLO Biotech Latest Developments

Table 204. Vazyme Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 205. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 206. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 207. Vazyme Biotech Main Business

Table 208. Vazyme Biotech Latest Developments

Table 209. EasyDiagnosis Biomedicine Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 210. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 211. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 212. EasyDiagnosis Biomedicine Main Business

Table 213. EasyDiagnosis Biomedicine Latest Developments

Table 214. Beijing Hotgen Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 215. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 216. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 217. Beijing Hotgen Biotech Main Business

Table 218. Beijing Hotgen Biotech Latest Developments

Table 219. Assure Tech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 220. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 221. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 222. Assure Tech Main Business

Table 223. Assure Tech Latest Developments

Table 224. Hangzhou AllTest Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 225. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 226. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 227. Hangzhou AllTest Biotech Main Business

Table 228. Hangzhou AllTest Biotech Latest Developments

Table 229. ACON Biotech Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 230. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 231. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 232. ACON Biotech Main Business

Table 233. ACON Biotech Latest Developments

Table 234. BGI Genomics Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 235. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 236. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 237. BGI Genomics Main Business

Table 238. BGI Genomics Latest Developments

Table 239. Lepu Medical Technology Basic Information, Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base, Sales Area and Its Competitors

Table 240. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product Offered

Table 241. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 242. Lepu Medical Technology Main Business

Table 243. Lepu Medical Technology Latest Developments

List of Figures

Figure 1. Picture of Rapid Antigen Testing (RAT) for COVID-19

Figure 2. Rapid Antigen Testing (RAT) for COVID-19 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Fluorescence Immunochromatography

Figure 10. Product Picture of Colloidal Gold Immunochromatography

Figure 11. Product Picture of Latex Immunochromatography

Figure 12. Product Picture of Others

Figure 13. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type in 2021

Figure 14. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2017-2022)

Figure 15. Rapid Antigen Testing (RAT) for COVID-19 Consumed in Hospitals

Figure 16. Global Rapid Antigen Testing (RAT) for COVID-19 Market: Hospitals (2017-2022) & (K Units)

Figure 17. Rapid Antigen Testing (RAT) for COVID-19 Consumed in Community Testing

Figure 18. Global Rapid Antigen Testing (RAT) for COVID-19 Market: Community Testing (2017-2022) & (K Units)

Figure 19. Rapid Antigen Testing (RAT) for COVID-19 Consumed in Other

Figure 20. Global Rapid Antigen Testing (RAT) for COVID-19 Market: Other (2017-2022) & (K Units)

Figure 21. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2017-2022)

Figure 22. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application in 2021

Figure 23. Rapid Antigen Testing (RAT) for COVID-19 Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Company in 2021

Figure 25. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Geographic Region in 2021

Figure 27. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2017-2022)

Figure 28. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country/Region in 2021

Figure 29. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales 2017-2022 (K Units)

Figure 30. Americas Rapid Antigen Testing (RAT) for COVID-19 Revenue 2017-2022 ($ Millions)

Figure 31. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales 2017-2022 (K Units)

Figure 32. APAC Rapid Antigen Testing (RAT) for COVID-19 Revenue 2017-2022 ($ Millions)

Figure 33. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales 2017-2022 (K Units)

Figure 34. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue 2017-2022 ($ Millions)

Figure 37. Americas Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country in 2021

Figure 38. Americas Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country in 2021

Figure 39. United States Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region in 2021

Figure 44. APAC Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Regions in 2021

Figure 45. China Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country in 2021

Figure 52. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country in 2021

Figure 53. Germany Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country in 2021

Figure 60. Egypt Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Rapid Antigen Testing (RAT) for COVID-19 in 2021

Figure 66. Manufacturing Process Analysis of Rapid Antigen Testing (RAT) for COVID-19

Figure 67. Industry Chain Structure of Rapid Antigen Testing (RAT) for COVID-19

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450